Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

  • There is currently no data for ALGW

Shareholder Update Call

27 Mar 2025 07:00

RNS Number : 4161C
Alpha Growth PLC
27 March 2025
 

 

 

REACH: non-regulatory announcement

Alpha Growth plc

("Alpha" or the "Company")

Shareholder Update Call

Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services company in the life insurance linked asset/wealth management business, announces that their leadership team will host a live interactive call on the Engage Investor platform, on the 2nd of April 2025, at 11:00am BST. 

Alpha Growth Plc welcomes all current shareholders to join and encourages shareholders to pre-submit questions. Investors can also submit questions at any time during the live presentation. 

Investors can sign up to Engage Investor at no cost and follow Alpha Growth Plc from their personalised investor hub.

Register interest in this event here: https://engageinvestor.news/alpha_IP25

 

Alpha Growth plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman

info@algwplc.com

 

Allenby Capital Limited

+44 (0) 20 3328 5656

Amrit Nahal (Sales and Corporate Broking)

Nick Athanas / Piers Shimwell (Corporate Finance)

 

UK Investor Relations - Mark Treharne

ir@algwplc.com

 

 

About Alpha Growth plc

 

Specialist in Longevity Assets

 

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets and insurance linked asset and wealth management. Building on its well-established network, the Alpha Growth group has a unique position in the insurance and asset services and investment business, as a listed entity with global reach. The group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

Longevity Assets and Non-correlation

 

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

 

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

 

***END***

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAEDXAEASEEA
Date   Source Headline
18th Dec 202011:05 amRNSSecond Price Monitoring Extn
18th Dec 202011:00 amRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSHolding(s) in Company
16th Dec 202011:05 amRNSSecond Price Monitoring Extn
16th Dec 202011:00 amRNSPrice Monitoring Extension
16th Dec 20207:00 amRNSOTC Listing
15th Dec 20202:05 pmRNSSecond Price Monitoring Extn
15th Dec 20202:00 pmRNSPrice Monitoring Extension
11th Dec 202011:05 amRNSSecond Price Monitoring Extn
11th Dec 202011:00 amRNSPrice Monitoring Extension
10th Dec 20204:41 pmRNSSecond Price Monitoring Extn
10th Dec 20204:36 pmRNSPrice Monitoring Extension
9th Dec 20202:06 pmRNSSecond Price Monitoring Extn
9th Dec 20202:01 pmRNSPrice Monitoring Extension
30th Nov 20204:02 pmRNSHolding(s) in Company
30th Nov 20202:06 pmRNSSecond Price Monitoring Extn
30th Nov 20202:01 pmRNSPrice Monitoring Extension
30th Nov 202011:06 amRNSSecond Price Monitoring Extn
30th Nov 202011:00 amRNSPrice Monitoring Extension
26th Nov 20204:41 pmRNSSecond Price Monitoring Extn
26th Nov 20204:35 pmRNSPrice Monitoring Extension
26th Nov 20202:06 pmRNSSecond Price Monitoring Extn
26th Nov 20202:00 pmRNSPrice Monitoring Extension
4th Nov 20207:00 amRNSCorporate Update
17th Sep 20201:00 pmRNSConfirm Previous Announced/Issued Shares Admission
10th Sep 20207:00 amRNSHolding(s) in Company
9th Sep 20206:24 pmRNSHolding(s) in Company
9th Sep 20206:20 pmRNSHolding(s) in Company
7th Sep 20204:41 pmRNSSecond Price Monitoring Extn
7th Sep 20204:36 pmRNSPrice Monitoring Extension
7th Sep 20202:06 pmRNSSecond Price Monitoring Extn
7th Sep 20202:01 pmRNSPrice Monitoring Extension
4th Sep 20202:17 pmRNSPublication of a Prospectus
19th Aug 20207:00 amRNSAppointment of Pello Capital Ltd and Placing
3rd Aug 20207:00 amRNSHolding(s) in Company
20th Jul 20207:00 amRNSCorporate Update
8th Jul 202011:05 amRNSSecond Price Monitoring Extn
8th Jul 202011:00 amRNSPrice Monitoring Extension
3rd Jul 20207:00 amRNSHolding(s) in Company
1st Jul 20207:00 amRNSHolding(s) in Company
24th Jun 20207:00 amRNSHolding(s) in Company
4th Jun 20207:00 amRNSHolding(s) in Company
29th May 20207:00 amRNSDirector/PDMR Dealing and Issue of Shares
28th May 20207:00 amRNSHalf-year Report
27th May 20204:40 pmRNSHolding(s) in Company
21st May 20206:20 pmRNSHolding(s) in Company
6th May 20207:00 amRNSHolding(s) in Company
1st May 202011:06 amRNSSecond Price Monitoring Extn
1st May 202011:00 amRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSPeriodic Corporate Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.